 |
市場調查報告書
商品編碼
1454861
消化器官系統的健康市場Digestive Health |
||||||
消化健康和腸道微生物組在各方面的作用是消費者保健領域最熱門的話題之一。市場開發商和消費者對 CHC 市場這一令人興奮的領域越來越感興趣，消費者已經在該領域建立了需求，並且預計將進一步發展。生物家族的健康益處已被廣泛接受並得到越來越多的科學證據的支持，這些證據支持其在越來越廣泛的類別中的功效，包括免疫、體重管理、皮膚健康以及心臟、大腦和關節健康。
同時，整個傳統的消化疾病類別，如抗酸劑、ORT、瀉藥和消化?，正在被現代快節奏、壓力大的生活方式以及消費者對消化疾病的了解不斷增加、有針對性的推出活動和回報所取代。
胃腸道藥物預計將成為未來5-10 年內成長最快的CHC 類別之一，預計將成為未來幾年成長最快的CHC 類別之一，包括食品不耐受、宿醉療法等有前景的關鍵領域和水合健康是發展的關鍵領域。
本報告詳細檢視了 10 個主要市場，總結了關鍵產品銷售、品牌表現、最新發展以及到 2033 年的長期預測。
目錄
摘要整理
巴西
- 概要
- 制酸劑
- 腸胃藥
- 瀉藥
- 口服補液療法
- 消化酵素
- 肝臟和膽汁療法
- 抗驚厥藥和腸躁症治療藥
- 其他的腸胃藥
- 益生菌
- 展望，預測，機會
中國
- 概要
- 制酸劑
- 瀉藥
- 止瀉
- 口服補液療法
- 噁心停
- 消化酵素
- 肝臟和膽汁療法
- 其他的腸胃藥
- 益生菌
- 展望，預測，機會
法國
- 概要
- 制酸劑
- 腸胃藥
- 瀉藥
- 止瀉
- 噁心停
- 肝臟和膽汁療法
- 抗驚厥藥和腸躁症治療藥
- 其他的腸胃藥
- 益生菌
- 展望，預測，機會
德國
- 概要
- 制酸劑
- 腸胃藥
- 瀉藥
- 止瀉
- 口服補液療法
- 噁心停
- 消化酵素
- 肝臟和膽汁療法
- 抗驚厥藥和腸躁症治療藥
- 其他的腸胃藥
- 益生菌
- 展望，預測，機會
印度
- 概要
- 制酸劑
- 腸胃藥
- 瀉藥
- 口服補液療法
- 消化酵素
- 肝臟和膽汁療法
- 傳統的消化療法
- 益生菌
- 展望，預測，機會
義大利
- 概要
- 制酸劑
- 腸胃藥
- 瀉藥
- 止瀉
- 噁心停
- 消化酵素
- 肝臟和膽汁療法
- 抗驚厥藥和腸躁症治療藥
- 益生菌
- 展望，預測，機會
日本
- 概要
- 制酸劑
- 腸胃藥
- 瀉藥
- 止瀉
- 噁心停
- 肝臟和膽汁療法
- 抗驚厥藥和腸躁症治療藥
- 傳統的消化療法
- 益生菌
- 展望，預測，機會
墨西哥
- 概要
- 制酸劑
- 腸胃藥
- 瀉藥
- 止瀉
- 口服補液療法
- 噁心停
- 肝臟和膽汁療法
- 抗驚厥藥和腸躁症治療藥
- 其他的腸胃藥
- 益生菌
- 展望，預測，機會
英國
- 概要
- 制酸劑
- 腸胃藥
- 瀉藥
- 止瀉
- 口服補液療法
- 噁心停
- 抗驚厥藥和腸躁症治療藥
- 益生菌
- 展望，預測，機會
美國
- 概要
- 制酸劑
- 腸胃藥
- 瀉藥
- 止瀉
- 口服補液療法
- 噁心停
- 消化酵素
- 肝臟和膽汁療法
- 其他的腸胃藥
- 益生菌
- 展望，預測，機會
市場概要
- 波蘭
- 韓國
- 西班牙
消化器官系統的健康的未來
- 概要
- 定義和NPD
- 擴大的益生菌市場
品牌案例
- doramin
- darukorakkusu
- erekutororitto
- 百事doAC
- tamuzu
預測
Digestive Health and the role of the gut microbiome in multiple facets of health is one of the hottest topics in consumer healthcare. Marketers and consumers are increasingly switched on to this exciting area of the CHC market that already has established demand among consumers and is ripe for further development. With widening acceptance of the health benefits of "the biotics family", the market is primed to expand via new launches across an ever-widening range of categories, including heart, brain and joint health, not to mention immunity, weight management and skin health, backed by a growing body of scientific evidence supporting their efficacy.
Meanwhile, a whole swathe of traditional GIs categories, including antacids, ORTs, laxatives, digestive enzymes & more, are being driven by factors such as modern fast-paced stressful lifestyles, rising consumer understanding of digestive conditions, targeted launch activity and a return to travelling in a post-Covid world.
Forecast to be among the fastest-growing CHC categories in the next 5-10 years, Gastrointestinals is a key arena for future development, including promising key niches such as food intolerance, hangover cures and rehydration wellness.
By examining 10 core markets in detail (and additional key markets in brief), analysing brand performances and launch activity, our "Digestive Health" report aims to investigate the untapped potential in this important CHC category.
Key Features of the report:
- An in-depth exploration of the CHC GIs & Probiotics market globally, including Antacids, Laxatives, Antidiarrhoeals, Liver & bile remedies, ORTs, Probiotics and more
- Coverage of 10 major markets from around the world, with topline sales, brand performances, the latest developments, launches and promotional campaigns PLUS mini-profiles of additional markets
- Very latest year-end 2023 sales from the
- just-published DB6, our dedicated CHC sales database, plus historical growth rates back to 2019
- Case studies of key brands, highlighting strategies and success factors, sales, NPD activity and consumer & HCP promotion
- A dedicated chapter investigates what the future holds for Digestive Health, examining the latest research into the gut-brain axis and new areas of development
- Forecast sales to 2024 & 2025 for all categories and countries, plus longer-term predictions to 2028 & 2033
The report features the latest end-2023 sales data from our dedicated DB6 database, including topline historical sales globally, by country and category, as well as individual brand performances, and long-term forecasts to 2028 and 2033.
Diving into the factors affecting the Gastrointestinals & Probiotics markets, from consumer trends and regulatory changes to A+P campaigns and new product launch activity, this report sheds light on trends & developments across 10 in-depth country rofiles with insights and predictions, as well as shorter profiles of other key markets.
A dedicated chapter - Digestive Health: What Does the Future Hold? - interrogates likely scenarios for the biotics family (probiotics, prebiotics, synbiotics & postbiotics), including the latest research into the gut-brain axis, the expanding role of gut flora in health and exciting areas of development such as probiotics for mental health, custom probiotics and the gut-muscle axis.
Key questions investigated in this report:
- What are the key differences from market to market in terms of growth drivers, consumer choices and competitive landscape?
- Which marketers and brands stand out and why?
- How will NPD benefit GIs & Probiotics in the years ahead?
- What are the opportunities for e-commerce and digital marketing?
- What new niches and demographics remain underserved?
- What does the future hold for Digestive Health brands?
10 individual markets profiled in depth:
|
|
Categories covered in this report include:
|
|
*sales tracked under VMS in DB6.
Table of Contents
Executive Summary
Brazil
- Overview
- Antacids
- Antiflatulents
- Laxatives
- Oral rehydration treatments
- Digestive enzymes
- Liver & bile remedies
- Antispasmodics & IBS remedies
- Other gastrointestinals
- Probiotics
- Outlook, forecast & opportunities
China
- Overview
- Antacids
- Laxatives
- Antidiarrhoeals
- Oral rehydration treatments
- Antinauseants
- Digestive enzymes
- Liver & bile remedies
- Other gastrointestinals
- Probiotics
- Outlook, forecast & opportunities
France
- Overview
- Antacids
- Antiflatulents
- Laxatives
- Antidiarrhoeals
- Antinauseants
- Liver & bile remedies
- Antispasmodics & IBS remedies
- Other gastrointestinals
- Probiotics
- Outlook, forecast & opportunities
Germany
- Overview
- Antacids
- Antiflatulents
- Laxatives
- Antidiarrhoeals
- Oral rehydration treatments
- Antinauseants
- Digestive enzymes
- Liver & bile remedies
- Antispasmodics & IBS remedies
- Other gastrointestinals
- Probiotics
- Outlook, forecast & opportunities
India
- Overview
- Antacids
- Antiflatulents
- Laxatives
- Oral rehydration treatments
- Digestive enzymes
- Liver & bile remedies
- Traditional digestive remedies
- Probiotics
- Outlook, forecast & opportunities
Italy
- Overview
- Antacids
- Antiflatulents
- Laxatives
- Antidiarrhoeals
- Antinauseants
- Digestive enzymes
- Liver & bile remedies
- Antispasmodics & IBS remedies
- Probiotics
- Outlook, forecast & opportunities
Japan
- Overview
- Antacids
- Antiflatulents
- Laxatives
- Antidiarrhoeals
- Antinauseants
- Liver & bile remedies
- Antispasmodics & IBS remedies
- Traditional digestive remedies
- Probiotics
- Outlook, forecast & opportunities
Mexico
- Overview
- Antacids
- Antiflatulents
- Laxatives
- Antidiarrhoeals
- Oral rehydration treatments
- Antinauseants
- Liver & bile remedies
- Antispasmodics & IBS remedies
- Other gastrointestinals
- Probiotics
- Outlook, forecast & opportunities
UK
- Overview
- Antacids
- Antiflatulents
- Laxatives
- Antidiarrhoeals
- Oral rehydration treatments
- Antinauseants
- Antispasmodics & IBS remedies
- Probiotics
- Outlook, forecast & opportunities
USA
- Overview
- Antacids
- Antiflatulents
- Laxatives
- Antidiarrhoeals
- Oral rehydration treatments
- Antinauseants
- Digestive enzymes
- Liver & bile remedies
- Other gastrointestinals
- Probiotics
- Outlook, forecast & opportunities
Markets in Brief
- Poland
- South Korea
- Spain
The Future of Digestive Health
- Overview
- Definitions & NPD
- The expanding probiotics market
Brand Case Studies
- Dramamine
- Dulcolax
- Electrolit
- Pepcid AC
- Tums
